CPHARM - CRC Study

Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low. Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.

Inclusion Criteria: * Adults aged 50 to 75 years who visit participating community pharmacies during the study period will be eligible to participate. Individuals must be able provide informed consent, and be willing to complete the questionnaire; consent for follow-up in the subsequent assessment of iFOBT provision, testing completion, and results. Exclusion Criteria: * Individuals with a prior diagnosis of colorectal cancer, a history of colonoscopy within the recommended screening interval (past 1 year), symptomatic of colorectal cancer, or those having first degree relative diagnosed colorectal cancer will be excluded.